LYRA Lyra Therapeutics Inc Operating Sales Margin

Public company logo of Lyra Therapeutics (LYRA)

Lyra Therapeutics, Inc. (LYRA) develops implants for the local treatment of ENT pathologies, generating revenue by supplying clinics with alternatives to surgery. The operating margin history demonstrates profit dynamics, where 0.00 captures a new level. The platform's versatility reduces regulatory risks, while standard environmental regulations ensure the safe disposal of chemical reagents in laboratories.

LYRA - lyratherapeutics.com Operating Profit Ratio over the range 07/04/2022 - 03/28/2026

Metric breakdowns and analytics for lyratherapeutics.com (LYRA)

- share price and consensus valuation forecast:
Fundamental company valuation:Lyra Therapeutics Inc., LYRA
Finished products of Lyra Therapeutics, Inc.

Full capacity utilization of biopharmaceutical lines and the absence of laboratory downtime at Lyra Therapeutics, Inc. (LYRA) directly determine the company's operating cost structure. This operating margin captures the share of profit from core operations before taxes and interest, allowing investors to track real-time resource management efficiency via the chart's dynamics and promptly detect fundamental shifts in business profitability.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.